ULGX

Urologix, Inc. ULGX

ULGX
Urologix, Inc. LPTI
Longport, Inc. CANQF
CanaQuest Medical Corp. NEWG
Greenwind Holdings Inc. COTQF
Cotinga Pharmaceuticals Inc. ETAOF
ETAO International Co., Ltd. THMO
ThermoGenesis Holdings, Inc. PZRXQ
PhaseRx, Inc. SVSO
SheerVision, Inc. ANTH
Anthera Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ULGX LPTI CANQF NEWG COTQF ETAOF THMO PZRXQ SVSO ANTH
6M 0.00 % 0.00 % -99.48 % 0.00 % 0.00 % 300.00 % 0.00 % 0.00 % 100.00 % 0.00 %
YTD 0.00 % 0.00 % -99.50 % 0.00 % 0.00 % 3 900.00 % -85.71 % -50.00 % 100.00 % -50.00 %
1Y 0.00 % 0.00 % -99.50 % 0.00 % 0.00 % 3 900.00 % -83.33 % -50.00 % 100.00 % 0.00 %
3Y 0.00 % 0.00 % -99.94 % 9 900.00 % 900.00 % -100.00 % -100.00 % 0.00 % -98.00 % 0.00 %
5Y -97.56 % -95.59 % -99.89 % 9 900.00 % -95.35 % -100.00 % -100.00 % -98.04 % -99.47 % -99.43 %
10Y -98.36 % -97.92 % -99.99 % 9 900.00 % -99.96 % -100.00 % -100.00 % -100.00 % -98.68 % -100.00 %
From the beginning -100.00 % -99.00 % -99.99 % 9 900.00 % -99.98 % -100.00 % -100.00 % -100.00 % -99.94 % -100.00 %

Dividend

Longport, Inc.